Levodopa, also known as L-DOPA, is a dopaminergic medication which is used in the treatment of Parkinson's disease (PD) and certain other conditions like dopamine-responsive dystonia and restless legs syndrome. The drug is usually used and formulated in combination with a peripherally selective aromatic L-amino acid decarboxylase (AAAD) inhibitor like carbidopa or benserazide. Levodopa is taken by mouth, by inhalation, through an intestinal tube, or by administration into fat.
Levodopa molecular structure diagram from the DrugsPRO substance library.
Also known as: L-DOPA, L-3,4-dihydroxyphenylalanine, Inbrija
Classification
Chemical: Medicine
Tag: Antiparkinson medicine
Tag: Dopaminergic
Effects
Relief Of Parkinsonian Symptoms
Nausea
Vomiting
Yawning
Orthostatic Hypotension
Sudden Sleep Onset
Drowsiness
Dizziness
Compulsive Behaviors
Hallucinations
Open Eye Visuals
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
Levodopa - DrugsPRO substansvejledning
Levodopa: Levodopa, also known as L-DOPA, is a dopaminergic medication which is used in the treatment of Parkinson's disease (PD) and certain other conditions like dopamine-responsive dystonia and restless legs syndrome. The drug is usually used and formulated in combination with a peripherally sele
